Global and Region Sickle Cell Anemia Treatment Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Sickle Cell Anemia Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Sickle Cell Anemia Treatmentmarket, defines the market attractiveness level of Sickle Cell Anemia Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Sickle Cell Anemia Treatment industry, describes the types of Sickle Cell Anemia Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Sickle Cell Anemia Treatment market and the development prospects and opportunities of Sickle Cell Anemia Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Sickle Cell Anemia Treatment market in Chapter 13.

    By Player:

    • BioMarin

    • Emmaus Medical

    • Modus Therapeutics

    • DeuteRx

    • Gamida Cell

    • Sancilio Pharmaceuticals

    • Sangamo Biosciences

    • Pfizer

    • GlycoMimetics

    • Bluebird Bio Bluebird Bio

    • Global Blood Therapeutics

    By Type:

    • Blood Transfusion

    • Pharmacotherapy

    • Bone Marrow Transplant

    By End-User:

    • Hospitals

    • Clinics

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Sickle Cell Anemia Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Sickle Cell Anemia Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Sickle Cell Anemia Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Sickle Cell Anemia Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Sickle Cell Anemia Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Sickle Cell Anemia Treatment Consumption (2017-2022)

    • 7.2 United States Sickle Cell Anemia Treatment Consumption (2017-2022)

    • 7.3 Europe Sickle Cell Anemia Treatment Consumption (2017-2022)

    • 7.4 China Sickle Cell Anemia Treatment Consumption (2017-2022)

    • 7.5 Japan Sickle Cell Anemia Treatment Consumption (2017-2022)

    • 7.6 India Sickle Cell Anemia Treatment Consumption (2017-2022)

    • 7.7 South Korea Sickle Cell Anemia Treatment Consumption (2017-2022)

    8 Region and Country-wise Sickle Cell Anemia Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Sickle Cell Anemia Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Sickle Cell Anemia Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Sickle Cell Anemia Treatment Consumption Forecast (2022-2028)

    • 8.4 China Sickle Cell Anemia Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Sickle Cell Anemia Treatment Consumption Forecast (2022-2028)

    • 8.6 India Sickle Cell Anemia Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Sickle Cell Anemia Treatment Consumption Forecast (2022-2028)

    9 Global Sickle Cell Anemia Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Sickle Cell Anemia Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Blood Transfusion Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Pharmacotherapy Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Bone Marrow Transplant Consumption and Growth Rate (2017-2022)

    • 9.2 Global Sickle Cell Anemia Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Sickle Cell Anemia Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Sickle Cell Anemia Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Blood Transfusion Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Pharmacotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Bone Marrow Transplant Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Sickle Cell Anemia Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Sickle Cell Anemia Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Sickle Cell Anemia Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Sickle Cell Anemia Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Sickle Cell Anemia Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Sickle Cell Anemia Treatment Market Competitive Analysis

    • 14.1 BioMarin

      • 14.1.1 BioMarin Company Details

      • 14.1.2 BioMarin Sickle Cell Anemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 BioMarin Sickle Cell Anemia Treatment Product and Service

    • 14.2 Emmaus Medical

      • 14.2.1 Emmaus Medical Company Details

      • 14.2.2 Emmaus Medical Sickle Cell Anemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Emmaus Medical Sickle Cell Anemia Treatment Product and Service

    • 14.3 Modus Therapeutics

      • 14.3.1 Modus Therapeutics Company Details

      • 14.3.2 Modus Therapeutics Sickle Cell Anemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Modus Therapeutics Sickle Cell Anemia Treatment Product and Service

    • 14.4 DeuteRx

      • 14.4.1 DeuteRx Company Details

      • 14.4.2 DeuteRx Sickle Cell Anemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 DeuteRx Sickle Cell Anemia Treatment Product and Service

    • 14.5 Gamida Cell

      • 14.5.1 Gamida Cell Company Details

      • 14.5.2 Gamida Cell Sickle Cell Anemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Gamida Cell Sickle Cell Anemia Treatment Product and Service

    • 14.6 Sancilio Pharmaceuticals

      • 14.6.1 Sancilio Pharmaceuticals Company Details

      • 14.6.2 Sancilio Pharmaceuticals Sickle Cell Anemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Sancilio Pharmaceuticals Sickle Cell Anemia Treatment Product and Service

    • 14.7 Sangamo Biosciences

      • 14.7.1 Sangamo Biosciences Company Details

      • 14.7.2 Sangamo Biosciences Sickle Cell Anemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Sangamo Biosciences Sickle Cell Anemia Treatment Product and Service

    • 14.8 Pfizer

      • 14.8.1 Pfizer Company Details

      • 14.8.2 Pfizer Sickle Cell Anemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Pfizer Sickle Cell Anemia Treatment Product and Service

    • 14.9 GlycoMimetics

      • 14.9.1 GlycoMimetics Company Details

      • 14.9.2 GlycoMimetics Sickle Cell Anemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 GlycoMimetics Sickle Cell Anemia Treatment Product and Service

    • 14.10 Bluebird Bio Bluebird Bio

      • 14.10.1 Bluebird Bio Bluebird Bio Company Details

      • 14.10.2 Bluebird Bio Bluebird Bio Sickle Cell Anemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Bluebird Bio Bluebird Bio Sickle Cell Anemia Treatment Product and Service

    • 14.11 Global Blood Therapeutics

      • 14.11.1 Global Blood Therapeutics Company Details

      • 14.11.2 Global Blood Therapeutics Sickle Cell Anemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Global Blood Therapeutics Sickle Cell Anemia Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Sickle Cell Anemia Treatment

    • Figure Sickle Cell Anemia Treatment Picture

    • Table Global Sickle Cell Anemia Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Sickle Cell Anemia Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Sickle Cell Anemia Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Sickle Cell Anemia Treatment Consumption by Country (2017-2022)

    • Figure United States Sickle Cell Anemia Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Sickle Cell Anemia Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Sickle Cell Anemia Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Sickle Cell Anemia Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Sickle Cell Anemia Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Sickle Cell Anemia Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Sickle Cell Anemia Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Sickle Cell Anemia Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Sickle Cell Anemia Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Sickle Cell Anemia Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Sickle Cell Anemia Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Sickle Cell Anemia Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Sickle Cell Anemia Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Transfusion Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmacotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Bone Marrow Transplant Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Transfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmacotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Bone Marrow Transplant Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Sickle Cell Anemia Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Sickle Cell Anemia Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table BioMarin (Foundation Year, Company Profile and etc.)

    • Table BioMarin Sickle Cell Anemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioMarin Sickle Cell Anemia Treatment Product and Service

    • Table Emmaus Medical (Foundation Year, Company Profile and etc.)

    • Table Emmaus Medical Sickle Cell Anemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Emmaus Medical Sickle Cell Anemia Treatment Product and Service

    • Table Modus Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Modus Therapeutics Sickle Cell Anemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Modus Therapeutics Sickle Cell Anemia Treatment Product and Service

    • Table DeuteRx (Foundation Year, Company Profile and etc.)

    • Table DeuteRx Sickle Cell Anemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table DeuteRx Sickle Cell Anemia Treatment Product and Service

    • Table Gamida Cell (Foundation Year, Company Profile and etc.)

    • Table Gamida Cell Sickle Cell Anemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gamida Cell Sickle Cell Anemia Treatment Product and Service

    • Table Sancilio Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Sancilio Pharmaceuticals Sickle Cell Anemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sancilio Pharmaceuticals Sickle Cell Anemia Treatment Product and Service

    • Table Sangamo Biosciences (Foundation Year, Company Profile and etc.)

    • Table Sangamo Biosciences Sickle Cell Anemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sangamo Biosciences Sickle Cell Anemia Treatment Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Sickle Cell Anemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Sickle Cell Anemia Treatment Product and Service

    • Table GlycoMimetics (Foundation Year, Company Profile and etc.)

    • Table GlycoMimetics Sickle Cell Anemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlycoMimetics Sickle Cell Anemia Treatment Product and Service

    • Table Bluebird Bio Bluebird Bio (Foundation Year, Company Profile and etc.)

    • Table Bluebird Bio Bluebird Bio Sickle Cell Anemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bluebird Bio Bluebird Bio Sickle Cell Anemia Treatment Product and Service

    • Table Global Blood Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Global Blood Therapeutics Sickle Cell Anemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Global Blood Therapeutics Sickle Cell Anemia Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.